The Drug Supply Chain Security Act (DSCSA), signed into law on Nov. 27, 2013, outlines steps to achieve interoperable, electronic tracing of products at the package level to identify and trace certain prescription drugs as they are distributed in the United States. These requirements will enhance the FDA’s ability to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful.
At McKesson, we’ve closely followed the DSCSA regulation and have continued to stay heavily engaged with the FDA, the manufacturing community and our competitors to help ensure that we are compliant and that our implementation plans are executed seamlessly across all aspects of the pharmaceutical supply chain.
Click here to learn how our company is helping customers prepare for these changes brought about by the DSCSA.
Share
Post
Post
Email